Innovating CAR T cell therapy for today and tomorrow

Cell & Gene Therapy Insights 2020; 6(6), 783–788


Published: 30 June 2020
Expert Insight
David Chang

A new era has emerged in the cancer treatment landscape as cell therapies demonstrate their potential to be game changing. Inherent limitations of autologous CAR T cell therapies exist, which can restrict their application. Therefore, further exploration into engineered allogeneic CAR T cell therapy is needed as early research in hematologic cancers has demonstrated the potential of this powerful immunotherapy.